尼日利亚医生因抗击河盲症获奖(2/2)
概述：尼日利亚医生Uche Amazigo是非洲地区抗击河盲症的领导者，她因在公共卫生领域的杰出贡献获得玛希隆王子奖。Hints:
Dr. Amazigo
Merck
ivermectin
校对：熔雪gemini
翻译&注解：Lucifer_jin
组长：vincit
答疑：vincit
发音点评：ziyibn
本期材料发音模仿地址：http://bulo.hujiang.com/menu/11885/item/733470/http://t1.g.hjfile.cn/listen/201302/201302180933375151244.mp3She describes how medical workers have sometimes had to struggle to deliver medicine, vitamin A and bed nets, to protect against the flies.
Dr. Amazigo successfully organized local treatment operations in communities. Now 117,000 communities under 19 African governments treat the disease locally.
In 1987, the drug manufacturer Merck launched a program to provide a medicine called ivermectin to all those affected by the disease. The company said it would provide the treatment for free as long as necessary through the community-directed program.
The infection not only causes blindness, it also causes a painful skin disease. Dr. Amazigo says the effects are especially difficult for women. Women are often socially rejected when their skin shows early signs of the disease.
But she says victims are more accepted now. She also says health providers and governments recognize community operations as very important to educating more than 120 million people at risk for the disease.她描述了医务人员是如何竭尽全力提供药品、维生素A和蚊帐来防范黑蝇的。
阿玛西格医生曾在社区成功地组织过当地的手术治疗。现在19个非洲国家政府的11.7万个社区可在当地治疗该疾病。
1987年，药品生产商默克公司开展了一个项目，为所有感染者提供一种名叫伊维菌素的药品。该公司表示，只要有需要，他们就会通过社区定向计划免费提供治疗。
感染不仅会导致失明，同时也可造成痛苦的皮肤疾病。阿玛西格医生表示，这种疾病的对女性的影响更为严重。通常女性在皮肤出现这种病早期症状的时候就会被社会所排斥。
但她也表示，现在患者更易被社会接受。同时她还说，医疗机构和政府认识到，社区手术治疗的重要意义更在于对超过1.2亿处于有疾病感染风险的人进行教育。
页:
[1]